CMS Energy(CMS)
Search documents
CMS Energy Announces Third Quarter Results, Introduces 2025 Guidance
Prnewswire· 2024-10-31 10:30
JACKSON, Mich., Oct. 31, 2024 /PRNewswire/ -- CMS Energy announced today reported earnings per share of $0.84 for the third quarter of 2024, compared to $0.60 per share for the same quarter in 2023. The company's adjusted earnings per share for the third quarter were $0.84, compared to $0.61 per share for the same quarter in 2023. For the first nine months of the year, the company reported $2.45 per share compared to $1.96 per share for the same timeframe in 2023. The company's adjusted earnings per share o ...
HeartCore Expands its CMS Platform Offering into a SaaS Delivery Model
GlobeNewswire News Room· 2024-10-30 12:30
NEW YORK and TOKYO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced it has expanded its flagship CMS platform to include a Software as a Service ("SaaS") model, in addition to its legacy on-premises version. As part of this transition, HeartCore will leverage the Amazon Web Services ("AWS") infrastructure and collaborate with the AWS team to enhance the pr ...
Stay Ahead of the Game With CMS Energy (CMS) Q3 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2024-10-29 14:21
Analysts on Wall Street project that CMS Energy (CMS) will announce quarterly earnings of $0.78 per share in its forthcoming report, representing an increase of 27.9% year over year. Revenues are projected to reach $1.83 billion, increasing 9.5% from the same quarter last year. The current level reflects an upward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections ...
CMS Energy (CMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2024-10-24 15:06
Wall Street expects a year-over-year increase in earnings on higher revenues when CMS Energy (CMS) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 31. ...
HeartCore Shifts its CMS Licensing Contracts to Drive Longer and Increased Sales Contracts
GlobeNewswire News Room· 2024-10-22 12:30
NEW YORK and TOKYO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced a strategic shift from annual contracts to multi-year agreements around its core software business contracts. Since achieving profitability across its software business in Q1 2024, HeartCore has maintained a strong focus on its sales and marketing strategies to drive growth and sustain pos ...
Consumers Energy Foundation Announces $500,000 for Projects in Ogemaw, Genesee Counties
Prnewswire· 2024-10-16 13:33
JACKSON, Mich., Oct. 16, 2024 /PRNewswire/ -- The Consumers Energy Foundation announced its 2024 Prosperity Award Winners today, with recipients in West Branch and Mundy Township each receiving $250,000 in grant funding for projects in their communities. The Prosperity Awards, one of three signature grant rounds offered by the Foundation each year, aim to support economic development and improve community welfare. "Accessible parks and inviting green spaces are a vital part of any thriving community," said ...
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
GlobeNewswire News Room· 2024-10-14 21:00
-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius -- -- National Reimbursement Payment Determination from CMS for its PoNS Controller Deferred to the Next Cycle -- NEWTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced t ...
CMS Energy to Announce Third Quarter Results on October 31
Prnewswire· 2024-10-10 20:30
JACKSON, Mich., Oct. 10, 2024 /PRNewswire/ -- CMS Energy announced today it will provide 2024 third quarter results along with a business and financial outlook at 9:30 a.m. EDT on Thursday, October 31, 2024. A webcast of the presentation will be available on CMS Energy's website, cmsenergy.com. An audio replay will be available approximately three hours after the webcast and will be archived for 30 days on CMS Energy's website in the "Investor Relations" section. CMS Energy (NYSE: CMS) is a Michigan-based e ...
HeartCore's CMS Platform Achieves Top Market Share in Japan for Nine Consecutive Years
GlobeNewswire News Room· 2024-10-10 12:30
NEW YORK and TOKYO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced its Content Management System ("CMS") platform has achieved top market share in sales value in Japan for nine consecutive years, according to ITR Corporation, an independent IT consulting and research firm. The report disclosed that HeartCore owns a leading 15.1% market share in Japan, wit ...
CMS Grants TDAPA Reimbursement for Vafseo® (vadadustat) beginning January 1, 2025
Prnewswire· 2024-10-10 12:00
Designed to help dialysis organizations incorporate new treatments into their practices, TDAPA provides two years of reimbursement in addition to the ESRD bundled rate A HCPCS code has also been assigned to Vafseo to facilitate reimbursement at dialysis organizations CAMBRIDGE, Mass., Oct. 10, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the Center for Medicare & Med ...